Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

TELEFLEX INC (TFX)

$132.10 +0.72% NYSE: TFX · 15-min delayed
  • WAYNE, Pennsylvania
  • Public · NYSE: TFX
  • 15,500 employees
$5.7BMarket cap
$2.0BRevenue · FY2025
-$905.6MNet income
15,500Employees
TFXNYSE
1972IPO

About TELEFLEX INC

Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$2.0B
Net income
-$905.6M
Total assets
$6.9B
Market cap
$5.7B
Gross margin
56.2%
Operating margin
5.9%
Net margin
-45.4%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$2.0B
Cost of revenue
$872.0M
Gross profit
$1.1B
Operating expenses
$1.0B
Operating income
$118.4M
Income tax
-$34.0M
Net income
-$905.6M
EPS (basic)
$-20.30
EPS (diluted)
$-20.25

Balance sheet

Total assets
$6.9B
Current assets
$1.9B
Total liabilities
$3.8B
Current liabilities
$762.0M
Shareholders’ equity
$3.1B

Cash flow

Operating cash flow
$340.7M
Investing cash flow
-$849.2M
Financing cash flow
$611.5M
Net cash flow
$126.2M

Statements via Polygon.io (SEC filings)

NYSE: TFX
$132.10 +0.72%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$100.34 $138.81

52-week range

Market cap
$5.7B
EPS (diluted)
$-20.25
Dividend yield
1.03%
Shares outstanding
43.5M
Open
Day range
Prev close
Volume
IPO date
Jun 1, 1972

Teleflex Inc (TFX) Stock Price

  • Reported a net loss of $905.6M in FY2025.
  • Revenue declined 29% from FY2021 to FY2025.
  • Gross margin of 56.2%, net margin -45.4%.
  • Trading 5% below its 52-week high.
  • Pays a dividend yielding about 1.03% annually.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review TELEFLEX INC.

Write a review
Newsroom

News about TELEFLEX INC

News & sentiment via Polygon.io

FAQ

Teleflex Inc: frequently asked questions

Is Teleflex Inc an American company?

Teleflex Inc is a US-based company headquartered in Wayne, Pennsylvania, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Teleflex Inc headquartered?

Teleflex Inc is headquartered in Wayne, Pennsylvania, United States.

Is Teleflex Inc publicly traded?

Yes — Teleflex Inc is a publicly traded company. Its stock trades under the ticker symbol TFX on the NYSE.

What does Teleflex Inc do?

Teleflex Inc is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →